Abstract:The abnormal growth of oligodendrocyte precursor cells (OPCs) significantly contributes to the progression of glioblastoma tumors. Hence, molecules that block OPC growth may be of therapeutic importance in treating gliomas. 2-Methoxyestradiol (2ME), an endogenous tubulin-interacting metabolite of estradiol, is effective against multiple proliferative disorders. Based on its anti-carcinogenic and anti-angiogenic actions, it is undergoing phase II clinical trials. We hypothesize that 2ME may prevent glioma growth by targeting OPC growth. Here, we tested this hypothesis by assessing the impact of 2ME on the growth of an OPC line, "Oli-neu", and dissected the underlying mechanism(s). Treatment with 2ME inhibited OPC growth in a concentration-dependent manner, accompanied by significant upregulation in the expression of p21 and p27, which are negative cell-cycle regulators. Moreover, treatment with 2ME altered OPC morphology from multi-arm processes to rounded cells. At concentrations of 1uM and greater, 2ME induced apoptosis, with increased expressions of caspase 3, PARP, and caspase-7 fragments, externalized phosphatidylserine staining/APOPercentage, and increased mitochondrial activity. Flow cytometry and microscopic analysis demonstrated that 2ME triggers endoreduplication in a concentration-dependent fashion. Importantly, 2ME induced cyclin E, JNK1/2, and p53 expression, as well as OPC fusion, which are key mechanisms driving endoreduplication and whole-genome duplication. Importantly, the inhibition of p53 with pifithrin-α rescued 2ME-induced endoreduplication. The pro-apoptotic and endoreduplication actions of 2ME were accompanied by the upregulation of survivin, cyclin A, Cyclin B, Cyclin D2, and ppRB. Similar growth inhibitory, apoptotic, and endoreduplication effects of 2ME were observed in CG4 cells. Taken together, our findings provide evidence that 2ME not only inhibits OPC growth and triggers apoptosis, but also activates OPCs into survival (fight or flight) mode, leading to endoreduplication. This inherent survival characteristic of OPCs may, in part, be responsible for drug resistance in gliomas, as observed for many tubulin-interacting drugs. Importantly, the fate of OPCs after 2ME treatment may depend on the cell-cycle status of individual cells. Combining tubulin-interfering molecules with drugs such as pifithrin-α that inhibit endoreduplication may help inhibit OPC/glioma growth and limit drug resistance.

1-Oxoeudesm-11(13)-eno-12,8a-lactone Induces G2/M Arrest and Apoptosis of Human Glioblastoma Cells in Vitro

1-Oxoeudesnn-11(13)-Ene-12,8 Alpha-Lactone-Induced Apoptosis Via Ros Generation And Mitochondria Activation In Mcf-7 Cells

1-oxoeudesm-11(13)-ene-12,8α-lactone-induced apoptosis via ROS generation and mitochondria activation in MCF-7 cells

Oleanen Induces Apoptosis of Cervical Cancer Cells by Up-Regulation of Bim

Eupalinolide O, a Novel Sesquiterpene Lactone from Eupatorium Lindleyanum DC., Induces Cell Cycle Arrest and Apoptosis in Human MDA-MB-468 Breast Cancer Cells.

β-elemene induces caspase-dependent apoptosis in human glioma cells in vitro through the upregulation of Bax and Fas/ FasL and downregulation of Bcl-2.

NF-κB Activation Was Involved in Reactive Oxygen Species-Mediated Apoptosis and Autophagy in 1-Oxoeudesm-11(13)-eno-12,8α-lactone-treated Human Lung Cancer Cells.

Effect of Celastrus orbiculatus Extract on Cell Proliferation and Apoptosis of U251 Cells and Its Molecular Mechanism

The cytotoxic effect of β-elemene against malignant glioma is enhanced by base-excision repair inhibitor methoxyamine

Eriodictyol Inhibits Proliferation, Metastasis and Induces Apoptosis of Glioma Cells via PI3K/Akt/NF-κB Signaling Pathway

β-elemene induces glioma cell apoptosis by downregulating survivin and its interaction with hepatitis B X-interacting protein.

3Β‐hydroxyolean‐12‐en‐27‐oic Acid: A Cytotoxic, Apoptosis‐Inducing Natural Drug Against COLO‐205 Cancer Cells.

2-Methoxyestradiol, an Endogenous 17β-Estradiol Metabolite, Induces Antimitogenic and Apoptotic Actions in Oligodendroglial Precursor Cells and Triggers Endoreduplication via the p53 Pathway

Beta-Elemene Inhibits Proliferation of Human Glioblastoma Cells and Causes Cell-Cycle G0/G1 Arrest Via Mutually Compensatory Activation of Mkk3 and Mkk6

Modulation of Apoptotic and Akt/PI3K/mTOR pathways to target Glioblastoma Cells using synthetic compound PGEA-AN

Ellagic acid inhibits proliferation and induces apoptosis in human glioblastoma cells.

Β-Elemene Inhibits Proliferation of Human Glioblastoma Cells Through the Activation of Glia Maturation Factor Β and Induces Sensitization to Cisplatin.

Deoxyelephantopin induces apoptosis and cell cycle arrest in GL261 glioblastoma cells

Oxymatrine Inhibits Proliferation and Migration While Inducing Apoptosis in Human Glioblastoma Cells

Oxyphyllanene B Overcomes Temozolomide Resistance in Glioblastoma: Structure–activity Relationship and Mitochondria-Associated ER Membrane Dysfunction

[Experimental study on apoptosis induced by elemene in glioma cells].